
Overview
Dr. Arash Rezazadeh Kalebasty is a board-certified UCI Health medical oncologist who specializes in the diagnosis and treatment of genitourinary cancers. His clinical interests include immunotherapy and orther targeted therapies to treat cancers of the prostate, bladder, kidney and testes.He earned his medical degree at Shahid Beheshti University of Medical Sciences in Tehran, Iran. He completed a residency in internal medicine and a fellowship in medical oncology and hematology at Kentucky’s University of Louisville School of Medicine.Rezazadeh has served as principal investigator in numerous clinical trials for genitourinary malignancies, particularly cancers of the bladder and prostate. Some of these trials have led to the approval of novel first-in-class cancer therapies.He has also presented his studies at numerous national and international cancer conferences and has published extensively in his field, with over 100 publications indexed on PubMed. He is a member of the American Society of Clinical Oncology, the European Society for Medical Oncology and the NRG Oncology Genitourinary Committee. He is also an editorial reviewer for the publicationsBladder CancerandAnnals of Case Reports.
Dr. Kalebasty is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy.
Dr. Kalebasty is board certified in American Board Of Internal Medicine - Medical Oncology. He is actively involved in clinical research, co-authoring 44 peer reviewed articles.
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 The City Drive South, Building 23, Orange, CA 92868
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UCI Health Chao Family Comprehensive Cancer Center
"Dr. Lauren C. Pinter-Brown is a board-certified, fellowship-trained UCI hematologist-oncologist who specializes in the diagnosis and treatment of patients with lymphomas.A nationally recognized expert, Pinter-Brown has a longstanding interest in malignant lymphoma, with a particular focus on T-cell and skin lymphomas. Her clinical interests also include antiphospholipid, B-cell lymphoma, Hodgkin's lymphoma, mycosis fungoides, non-Hodgkins lymphoma, stem-cell transplant and Waldenstrom's disease.She her medical degree at the David Geffen School of Medicine at UCLA Medical School, followed by an internship and residency in internal medicine at Harbor-UCLA Medical Center. She completed a fellowship in hematology and oncology at the Keck School of Medicine at USC.A prolific clinical investigator, Pinter-Brown has made important contributions to several clinical trials that led to approval of new drugs for the treatment of T-cell lymphoma. Her research focus is on optimizing treatment options for patients with lymphoma, especially cutaneous and T-cell lymphomas. Her primary goal is to care for patients through diagnosis, treatment and beyond and to ensure that they are able ""to live their best life.""". Dr. Pinter-Brown is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Transplant. Dr. Pinter-Brown is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.
UCI Health Chao Family Comprehensive Cancer Center
Dr. Stefan O. Ciurea is a UCI Health hematologist and director of the Hematopoietic Stem Cell Transplantation and Cellular Therapy Program at the Chao Family Comprehensive Cancer Center.Ciurea earned his medical degree at Grigore T. Popa University of Medicine and Pharmaceuticals in Iasi, Romania. He completed an internal medicine residency at UPMC Pinnacle Harrisburg in Harrisburg, Pa. He then completed a fellowship in hematology-oncology at University of Illinois at Chicago College of Medicine, followed by a fellowship in stem cell transplantation and cellular therapy at the University of Texas MD Anderson Cancer Center in Houston.Before joining the Chao Family Comprehensive Cancer Center to lead its program in hematopoietic stem cell transplantation and cellular therapy, Ciurea served for more than a decade on the faculty of the MD Anderson Cancer Center’s Department of Stem Cell Transplantation and Cellular Therapy.Ciurea is the author of more than 150 peer-reviewed publications and more than 10 book chapters. He also has served as principal investigator on multiple clinical trials, including investigator-initiated trials. He has been invited to speak at more than 50 meetings and conferences around the world, including as keynote speaker. Dr. Ciurea is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ciurea is board certified in American Board Of Internal Medicine - Hematology.
UCI Health Chao Family Comprehensive Cancer Center
Dr. Misako Nagasaka is a board-certified UCI Health oncologist who specializes in the diagnosis and treatment of lung and thyroid cancers. Her clinical interests also early-phase clinical trials, medical ethics and survivorship care for patients.She received her medical degree as well as a PhD from St. Marianna University School of Medicine in Kawasaki, Japan. She completed a residency in internal medicine at Mount Sinai Beth Israel Hospital in New York City, followed by a fellowship in hematology and oncology at Wayne State University School of Medicine's Karmanos Cancer Institute in Detroit, Mich.Her research interests include molecular targeted therapy for lung cancer, immunotherapy and ways to improve patient outcomes. Prior to joining UCI Health, she served as an assistant professor and researcher at Wayne State and the Karmanos institute, she was the principal site investigator on more than 20 lung cancer studies.Nagasaka, who is fluent in Japanese, sees patients at the UCI HealthChao Family Comprehensive Cancer Center in Orange. Dr. Nagasaka is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Gastrostomy. Dr. Nagasaka is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine. Dr. Nagasaka is currently accepting new patients.
Frequently Asked Questions about Dr. Arash R. Kalebasty
How do I make an appointment with Dr. Arash R. Kalebasty?
You can book an appointment with Dr. Arash R. Kalebasty by calling their office at 714-456-8000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Arash R. Kalebasty a top-rated expert for Familial Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Arash R. Kalebasty is classified as an Elite expert for Familial Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Arash R. Kalebasty specialize in?
While Dr. Arash R. Kalebasty is a Hematology, they have specific expertise in Familial Prostate Cancer, Urothelial Cancer, and Renal Cell Carcinoma (RCC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Arash R. Kalebasty participate in research or clinical trials?
Yes. Dr. Arash R. Kalebasty has published 44 articles and abstracts on conditions like Familial Prostate Cancer. You can view a list of Dr. Arash R. Kalebasty's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Arash R. Kalebasty accept my insurance?
Dr. Arash R. Kalebasty accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 714-456-8000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Familial Prostate CancerDr. Kalebasty isElite. Learn about Familial Prostate Cancer.
- Distinguished
- Adult Soft Tissue SarcomaDr. Kalebasty isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Kalebasty isDistinguished. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Kalebasty isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Kalebasty isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Kalebasty isDistinguished. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Kalebasty isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Kalebasty isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Kalebasty isDistinguished. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Kalebasty isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Kalebasty isDistinguished. Learn about Upper Tract Urothelial Carcinoma (UTUC).
- Urothelial CancerDr. Kalebasty isDistinguished. Learn about Urothelial Cancer.
- Wilms TumorDr. Kalebasty isDistinguished. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Kalebasty isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Urachal CancerDr. Kalebasty isAdvanced. Learn about Urachal Cancer.
- Experienced
- Adrenal CancerDr. Kalebasty isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Kalebasty isExperienced. Learn about Adrenocortical Carcinoma.
- Alveolar Soft Part SarcomaDr. Kalebasty isExperienced. Learn about Alveolar Soft Part Sarcoma.
- B-Cell LymphomaDr. Kalebasty isExperienced. Learn about B-Cell Lymphoma.
- Bone TumorDr. Kalebasty isExperienced. Learn about Bone Tumor.
- Carcinoid SyndromeDr. Kalebasty isExperienced. Learn about Carcinoid Syndrome.
- ChoriocarcinomaDr. Kalebasty isExperienced. Learn about Choriocarcinoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Kalebasty isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Kalebasty isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Kalebasty isExperienced. Learn about Colorectal Cancer.
- Desmoplastic Small Round Cell TumorDr. Kalebasty isExperienced. Learn about Desmoplastic Small Round Cell Tumor.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Kalebasty isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Epithelioid SarcomaDr. Kalebasty isExperienced. Learn about Epithelioid Sarcoma.
- Essential ThrombocythemiaDr. Kalebasty isExperienced. Learn about Essential Thrombocythemia.
- Familial Colorectal CancerDr. Kalebasty isExperienced. Learn about Familial Colorectal Cancer.
- FibrosarcomaDr. Kalebasty isExperienced. Learn about Fibrosarcoma.
- Follicular LymphomaDr. Kalebasty isExperienced. Learn about Follicular Lymphoma.
- GanglioneuroblastomaDr. Kalebasty isExperienced. Learn about Ganglioneuroblastoma.
- GanglioneuromaDr. Kalebasty isExperienced. Learn about Ganglioneuroma.
- Gastric LymphomaDr. Kalebasty isExperienced. Learn about Gastric Lymphoma.
- Hereditary NeuroblastomaDr. Kalebasty isExperienced. Learn about Hereditary Neuroblastoma.
- Hereditary Paraganglioma-Pheochromocytoma Syndrome
- Large-Cell Immunoblastic LymphomaDr. Kalebasty isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- LeukocytosisDr. Kalebasty isExperienced. Learn about Leukocytosis.
- LiposarcomaDr. Kalebasty isExperienced. Learn about Liposarcoma.
- Lung CancerDr. Kalebasty isExperienced. Learn about Lung Cancer.
- Lung NodulesDr. Kalebasty isExperienced. Learn about Lung Nodules.
- Lymphofollicular HyperplasiaDr. Kalebasty isExperienced. Learn about Lymphofollicular Hyperplasia.
- Lynch SyndromeDr. Kalebasty isExperienced. Learn about Lynch Syndrome.
- Malignant Peripheral Nerve Sheath TumorDr. Kalebasty isExperienced. Learn about Malignant Peripheral Nerve Sheath Tumor.
- Mantle Cell Lymphoma (MCL)Dr. Kalebasty isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Marginal Zone Lymphoma (MZL)Dr. Kalebasty isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- MelanomaDr. Kalebasty isExperienced. Learn about Melanoma.
- MesenchymomaDr. Kalebasty isExperienced. Learn about Mesenchymoma.
- Myxoid LiposarcomaDr. Kalebasty isExperienced. Learn about Myxoid Liposarcoma.
- NephrectomyDr. Kalebasty isExperienced. Learn about Nephrectomy.
- NeuroblastomaDr. Kalebasty isExperienced. Learn about Neuroblastoma.
- Neuroendocrine TumorDr. Kalebasty isExperienced. Learn about Neuroendocrine Tumor.
- Non-Hodgkin LymphomaDr. Kalebasty isExperienced. Learn about Non-Hodgkin Lymphoma.
- OrchiectomyDr. Kalebasty isExperienced. Learn about Orchiectomy.
- Penile CancerDr. Kalebasty isExperienced. Learn about Penile Cancer.
- PheochromocytomaDr. Kalebasty isExperienced. Learn about Pheochromocytoma.
- PlasmacytomaDr. Kalebasty isExperienced. Learn about Plasmacytoma.
- Pleuropulmonary BlastomaDr. Kalebasty isExperienced. Learn about Pleuropulmonary Blastoma.
- Primary Lymphoma of the BrainDr. Kalebasty isExperienced. Learn about Primary Lymphoma of the Brain.
- Pseudomyxoma PeritoneiDr. Kalebasty isExperienced. Learn about Pseudomyxoma Peritonei.
- Pulmonary EmbolismDr. Kalebasty isExperienced. Learn about Pulmonary Embolism.
- Retroperitoneal LiposarcomaDr. Kalebasty isExperienced. Learn about Retroperitoneal Liposarcoma.
- Rhabdoid TumorDr. Kalebasty isExperienced. Learn about Rhabdoid Tumor.
- Rhabdoid Tumor Predisposition SyndromeDr. Kalebasty isExperienced. Learn about Rhabdoid Tumor Predisposition Syndrome.
- RhabdomyosarcomaDr. Kalebasty isExperienced. Learn about Rhabdomyosarcoma.
- Rhabdomyosarcoma EmbryonalDr. Kalebasty isExperienced. Learn about Rhabdomyosarcoma Embryonal.
- Richter SyndromeDr. Kalebasty isExperienced. Learn about Richter Syndrome.
- Synovial SarcomaDr. Kalebasty isExperienced. Learn about Synovial Sarcoma.
- Teratoma of the MediastinumDr. Kalebasty isExperienced. Learn about Teratoma of the Mediastinum.
- Testicular CancerDr. Kalebasty isExperienced. Learn about Testicular Cancer.
- Testicular Yolk Sac TumorDr. Kalebasty isExperienced. Learn about Testicular Yolk Sac Tumor.
- Undifferentiated Pleomorphic SarcomaDr. Kalebasty isExperienced. Learn about Undifferentiated Pleomorphic Sarcoma.
- Vitamin D DeficiencyDr. Kalebasty isExperienced. Learn about Vitamin D Deficiency.


